Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that UNC-2025 has similar subnanomolar activity against Flt3
and it has demonstrated selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that make up the normal
NVP-231 (0-1000 nM
Smiles: CC(C)C1=CC(=C(C=C1F)OC)C1=CC=C(C=C1CN1[C@@H](C)[C@H](OC1=O)C1C=C(C=C(C=1)C(F)(F)F)C(F)(F)F)C(F)(F)F
Carvedilol phosphate hemihydrate - CAS# 610309-89-2 2515 Kinome profiling versus more thanCarvedilol phosphate hemihydrate (BM 14190 phosphate hemihydrate) is a non selective 1 blocker. Carvedilol phosphate hemihydrate inhibits lipid peroxidation with an IC50 of 5 M. Carvedilol phosphate hemihydrate is a multiple action antihypertensive agent with potential use in angina and congestive heart failure. Carvedilol phosphate hemihydrate is an autophagy inducer that inhibits the NLRP3 inflammasome. Product information CAS Number: 610309 89 2
US$ 180.00
US$ 18.00
US$ 829.96
US$ 663.86
US$ 319.77
US$ 951.05